• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢甲状腺肿中的肿瘤:综述。

Neoplasms in Struma Ovarii: A Review.

机构信息

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA.

Department of Laboratories, Seattle Children's Hospital, Seattle, WA, 98105, USA.

出版信息

Endocr Pathol. 2023 Dec;34(4):455-460. doi: 10.1007/s12022-023-09789-7. Epub 2023 Oct 21.

DOI:10.1007/s12022-023-09789-7
PMID:37864665
Abstract

Struma ovarii is a well-known ovarian teratoma made up of benign thyroid tissue. These lesions demonstrate variable, normal architecture and normal thyroid immunohistochemical staining with positivity for TTF1, PAX8, and thyroglobulin. Though most are benign, some of these lesions can also present with a malignant component. Within this article, we review the most common diagnostic malignancies including papillary thyroid carcinoma, strumal carcinoid, highly differentiated follicular thyroid carcinoma, and other thyroid carcinomas. We additionally review the use of TTF1 staining to assist in differentiating these lesions from surrounding gynecologic epithelium, which is imperative in making such diagnoses. In highlighting these entities, we hope to provide practicing pathologists with an effective and concise review of these lesions to assist in more challenging cases of struma ovarii.

摘要

卵巢甲状腺肿是一种由良性甲状腺组织构成的、众所周知的卵巢畸胎瘤。这些病变表现出不同的、正常的结构,并且 TTF1、PAX8 和甲状腺球蛋白的免疫组织化学染色呈阳性,为良性。虽然大多数是良性的,但这些病变中的一些也可能存在恶性成分。在本文中,我们复习了最常见的诊断恶性肿瘤,包括甲状腺乳头状癌、甲状腺滤泡癌、甲状腺髓样癌和其他甲状腺癌。我们还复习了 TTF1 染色在鉴别这些病变与周围妇科上皮的作用,这对做出这些诊断至关重要。通过强调这些实体,我们希望为临床病理医生提供这些病变的有效和简洁的复习,以帮助处理更具挑战性的卵巢甲状腺肿病例。

相似文献

1
Neoplasms in Struma Ovarii: A Review.卵巢甲状腺肿中的肿瘤:综述。
Endocr Pathol. 2023 Dec;34(4):455-460. doi: 10.1007/s12022-023-09789-7. Epub 2023 Oct 21.
2
Pathology of Struma Ovarii: A Report of 96 Cases.卵巢甲状腺肿的病理学:96例报告
Endocr Pathol. 2015 Dec;26(4):342-8. doi: 10.1007/s12022-015-9396-1.
3
Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.卵巢甲状腺肿中典型甲状腺型癌:4例报告并文献复习
Int J Gynecol Pathol. 2008 Oct;27(4):496-506. doi: 10.1097/PGP.0b013e31816a74c6.
4
It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii.它确实存在!卵巢甲状腺肿起源的甲状腺癌的诊断与治疗。
Surg Pathol Clin. 2023 Mar;16(1):75-86. doi: 10.1016/j.path.2022.09.008. Epub 2022 Dec 13.
5
Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.Graves 病、甲状腺乳头状癌和单侧良性卵巢甲状腺肿共存:病例报告及文献复习。
Metabolism. 2013 Oct;62(10):1350-6. doi: 10.1016/j.metabol.2013.05.013. Epub 2013 Jun 24.
6
A case of malignant strumal carcinoid.一例恶性甲状腺类癌。
Gynecol Oncol. 1993 Dec;51(3):419-23. doi: 10.1006/gyno.1993.1316.
7
Papillary thyroid carcinoma in Struma Ovarii.卵巢甲状腺肿中的乳头状甲状腺癌。
Gynecol Endocrinol. 2020 Aug;36(8):749-752. doi: 10.1080/09513590.2020.1725966. Epub 2020 Feb 11.
8
Papillary carcinoma arising in struma ovarii versus ovarian metastasis from primary thyroid carcinoma: a case report and review of the literature.卵巢甲状腺肿中发生的乳头状癌与原发性甲状腺癌的卵巢转移:一例报告并文献复习
J Radiol Case Rep. 2013 Oct 1;7(10):24-33. doi: 10.3941/jrcr.v7i10.1593. eCollection 2013 Oct.
9
Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report.卵巢甲状腺型乳头状和低分化癌恶性甲状腺肿:一例报告。
J Med Case Rep. 2022 Sep 30;16(1):348. doi: 10.1186/s13256-022-03590-6.
10
Histopathologic aspects in a case of strumal carcinoid (struma ovarii and carcinoid).
Rom J Morphol Embryol. 1990 Apr-Jun;36(2):125-7.

引用本文的文献

1
The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism.普萘洛尔及其他β受体阻滞剂在甲状腺功能亢进症中的治疗潜力
Int J Mol Sci. 2025 Aug 27;26(17):8322. doi: 10.3390/ijms26178322.
2
Individualized survival prediction and risk stratification using machine learning for patients with malignant struma ovarii: a population-based study with external validation.使用机器学习对恶性卵巢甲状腺肿患者进行个体化生存预测和风险分层:一项基于人群并经外部验证的研究
Gland Surg. 2025 Jun 30;14(6):1052-1065. doi: 10.21037/gs-2025-35. Epub 2025 Jun 26.
3
Malignant Struma Ovarii: A Rare Manifestation of Ectopic Thyroid Cancer.

本文引用的文献

1
Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid.卵巢甲状腺类癌患者的临床特征和生存结局。
BMC Cancer. 2022 Oct 24;22(1):1090. doi: 10.1186/s12885-022-10167-5.
2
Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report.卵巢甲状腺型乳头状和低分化癌恶性甲状腺肿:一例报告。
J Med Case Rep. 2022 Sep 30;16(1):348. doi: 10.1186/s13256-022-03590-6.
3
Malignant Clinical Course of "Proliferative" Ovarian Struma: Diagnostic Challenges and Treatment Pitfalls.
恶性卵巢甲状腺肿:异位甲状腺癌的一种罕见表现。
JCEM Case Rep. 2025 Jul 10;3(8):luaf149. doi: 10.1210/jcemcr/luaf149. eCollection 2025 Aug.
4
Struma ovarii-diagnostic and treatment strategy: a case report.卵巢甲状腺肿的诊断与治疗策略:一例病例报告
J Med Case Rep. 2025 Jun 19;19(1):285. doi: 10.1186/s13256-025-05152-y.
5
Surgical approach and recurrence risk in struma ovarii: A retrospective and systematic analysis.卵巢甲状腺肿的手术方式与复发风险:一项回顾性系统分析
Biomol Biomed. 2025 Apr 3;25(5):1092-1098. doi: 10.17305/bb.2024.11287.
6
Teratoma combined with struma ovarii and sarcomatoid carcinoma: a case report and review of the literature.畸胎瘤合并卵巢甲状腺肿和肉瘤样癌:病例报告及文献复习。
BMC Womens Health. 2024 Sep 14;24(1):517. doi: 10.1186/s12905-024-03354-y.
“增殖性”卵巢甲状腺肿的恶性临床病程:诊断挑战与治疗陷阱
Diagnostics (Basel). 2022 Jun 7;12(6):1411. doi: 10.3390/diagnostics12061411.
4
Survival Outcomes and Prognostic Predictors in Patients With Malignant Struma Ovarii.恶性卵巢甲状腺肿患者的生存结果和预后预测因素
Front Med (Lausanne). 2021 Dec 23;8:774691. doi: 10.3389/fmed.2021.774691. eCollection 2021.
5
Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary.局限于卵巢的恶性卵巢甲状腺肿的临床特征和生存结局。
BMC Cancer. 2021 Apr 9;21(1):383. doi: 10.1186/s12885-021-08118-7.
6
Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal Carcinoids.13 例伴纤维间质的类癌的免疫组织化学特征和 47 基因下一代测序(NGS)实体肿瘤 panel 分析
Endocr Pathol. 2020 Jun;31(2):101-107. doi: 10.1007/s12022-020-09608-3.
7
Ki67 Proliferative Index in Carcinoid Tumors Involving Ovary.Ki67 增殖指数在卵巢类癌肿瘤中的应用。
Endocr Pathol. 2018 Mar;29(1):43-48. doi: 10.1007/s12022-017-9510-7.
8
Primary ovarian mixed strumal and mucinous carcinoid arising in an ovarian mature cystic teratoma.起源于卵巢成熟囊性畸胎瘤的原发性卵巢混合性甲状腺肿和黏液性类癌。
J Obstet Gynaecol Res. 2016 Feb;42(2):211-6. doi: 10.1111/jog.12878. Epub 2015 Nov 26.
9
Pathology of Struma Ovarii: A Report of 96 Cases.卵巢甲状腺肿的病理学:96例报告
Endocr Pathol. 2015 Dec;26(4):342-8. doi: 10.1007/s12022-015-9396-1.
10
Ovarian strumal carcinoid containing appendiceal-type mucinous tumor patterns presenting as pseudomyxoma peritonei.含有阑尾型黏液性肿瘤模式的卵巢甲状腺肿类癌表现为腹膜假黏液瘤。
Int J Gynecol Pathol. 2015 May;34(3):293-7. doi: 10.1097/PGP.0000000000000138.